Chinese researchers develop immunotherapeutic agent for colon cancer
Release time:2024-04-30 10:25:33
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for 。
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
Related articles
FAU's Vladislav Goldin to join Dusty May at Michigan, pulls name out of NBA draft
Vladislav Goldin has withdrawn from the NBA draft and will join his coach from Florida Atlantic, Dus2024-04-30Kenneth Eugene Smith: Alabama carries out first US nitrogen gas execution
In 2022, Alabama tried and failed to execute Smith by lethal injection. Photo: AFP photo / Alabama2024-04-30Tāngarākau campground murder: Justice Williamson
By Tara Shaskey, Open Justice reporter of2024-04-30Could the genocide case against Israel at the UN's top court have an impact on the war in Gaza?
By Audrey Courty, ABC NewsChildren inspect the damage following Israeli bombardment in Rafah on the2024-04-30Immersive Studio Ghibli exhibition opens in Shanghai
An immersive Studio Ghibli exhibition showcasing the art and insights of legendary Japanese animator2024-04-30- Photo: RNZ / Angus Dreaver2024-04-30
atest comment